These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10433926)

  • 21. Germline mutational analysis of CDH1 and pathologic features in familial cancer syndrome with diffuse gastric cancer/breast cancer proband in a Chinese family.
    Zhu ZG; Yu YY; Zhang Y; Ji J; Zhang J; Liu BY; Chen XH; Lu Y; Jiang HS; Bu L; Hu LD; Kong XY
    Eur J Surg Oncol; 2004 Jun; 30(5):531-5. PubMed ID: 15135482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
    Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
    Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
    Graziano F; Humar B; Guilford P
    Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.
    Schrader KA; Masciari S; Boyd N; Salamanca C; Senz J; Saunders DN; Yorida E; Maines-Bandiera S; Kaurah P; Tung N; Robson ME; Ryan PD; Olopade OI; Domchek SM; Ford J; Isaacs C; Brown P; Balmana J; Razzak AR; Miron P; Coffey K; Terry MB; John EM; Andrulis IL; Knight JA; O'Malley FP; Daly M; Bender P; ; Moore R; Southey MC; Hopper JL; Garber JE; Huntsman DG
    J Med Genet; 2011 Jan; 48(1):64-8. PubMed ID: 20921021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A germline E-cadherin mutation in a family with gastric and colon cancer.
    Salahshor S; Hou H; Diep CB; Loukola A; Zhang H; Liu T; Chen J; Iselius L; Rubio C; Lothe RA; Aaltonen L; Sun XF; Lindmark G; Lindblom A
    Int J Mol Med; 2001 Oct; 8(4):439-43. PubMed ID: 11562785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
    Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
    Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma.
    Djerroudi L; Bendali A; Fuhrmann L; Benoist C; Pierron G; Masliah-Planchon J; Kieffer Y; Carton M; Tille JC; Cyrta J; Ramtohul T; Bonneau C; Caly M; Renault V; Bidard FC; Mechta-Grigoriou F; Vincent-Salomon A
    Mod Pathol; 2024 Oct; 37(10):100570. PubMed ID: 39025406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.
    Corso G; Figueiredo J; La Vecchia C; Veronesi P; Pravettoni G; Macis D; Karam R; Lo Gullo R; Provenzano E; Toesca A; Mazzocco K; Carneiro F; Seruca R; Melo S; Schmitt F; Roviello F; De Scalzi AM; Intra M; Feroce I; De Camilli E; Villardita MG; Trentin C; De Lorenzi F; Bonanni B; Galimberti V
    J Med Genet; 2018 Jul; 55(7):431-441. PubMed ID: 29929997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations.
    Corso G; De Scalzi A; Feroce I; Veronesi P; Bonanni B; Galimberti V
    Per Med; 2018 May; 15(3):153-155. PubMed ID: 29745790
    [No Abstract]   [Full Text] [Related]  

  • 31. E-cadherin germline mutation carriers: clinical management and genetic implications.
    Corso G; Figueiredo J; Biffi R; Trentin C; Bonanni B; Feroce I; Serrano D; Cassano E; Annibale B; Melo S; Seruca R; De Lorenzi F; Ferrara F; Piagnerelli R; Roviello F; Galimberti V
    Cancer Metastasis Rev; 2014 Dec; 33(4):1081-94. PubMed ID: 25332147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low frequency of E-cadherin alterations in familial breast cancer.
    Salahshor S; Haixin L; Huo H; Kristensen VN; Loman N; Sjöberg-Margolin S; Borg A; Børresen-Dale AL; Vorechovsky I; Lindblom A
    Breast Cancer Res; 2001; 3(3):199-207. PubMed ID: 11305955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.
    Black MD; Kaneshiro R; Lai JI; Shimizu DM
    Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene.
    Rahman N; Stone JG; Coleman G; Gusterson B; Seal S; Marossy A; Lakhani SR; Ward A; Nash A; McKinna A; A'Hern R; Stratton MR; Houlston RS
    Br J Cancer; 2000 Feb; 82(3):568-70. PubMed ID: 10682667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
    Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
    Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
    Corso G; Marrelli D; Pascale V; Vindigni C; Roviello F
    BMC Cancer; 2012 Jan; 12():8. PubMed ID: 22225527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary diffuse gastric cancer: association with lobular breast cancer.
    Schrader KA; Masciari S; Boyd N; Wiyrick S; Kaurah P; Senz J; Burke W; Lynch HT; Garber JE; Huntsman DG
    Fam Cancer; 2008; 7(1):73-82. PubMed ID: 18046629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hereditary diffuse gastric cancer].
    Puchmajerová A; Vasovčák P; Macháčková E; Foretová L; Křepelová A
    Klin Onkol; 2012; 25 Suppl():S30-3. PubMed ID: 22920204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.